Milestone Metrics for Growth Stage Companies

03 November 2010 Past Event

In today’s business climate, medical device and life sciences companies need to be properly positioned at each phase of development with the appropriate plans in place for later portfolio development stages. Panelists will review key business and intellectual property management tools and strategies that are needed at the early-, mid- and late-growth stages as well the types of funding needed to fuel growth throughout the product life cycle. We also will address how and when you should plan for an IPO as well as other exit strategies, including merger and acquisitions.

Topics include:

  • How companies can balance the need to continually innovate while minimizing the failure rate
  • How to realize revenue streams earlier in the process
  • How to evaluate innovation based on potential business value


  • Jeff Draa, Board of Directors, Tech Coast Angels
  • Gabor Garai, Partner, Foley & Lardner
  • Vanessa Herbert, Senior Manager, PricewaterhouseCoopers
  • Keith Lindenbaum, Partner, Foley & Lardner LLP
  • Robert Mashal, M.D., President & CEO, NKT Therapeutics
  • David Parrot, M.B.A., Managing Director, BMO Capital Markets Corp.